RNA Sequencing Reveals Cancer‐Associated Changes in Laryngeal Cells Exposed to Non‐Acid Pepsin

Laryngopharyngeal reflux (LPR) is a common affliction that contributes to laryngeal inflammation, symptoms that impact quality of life, and life‐threatening illnesses such as cancer. Effective treatment strategies for LPR are lacking. Pepsin is a proinflammatory and carcinogenic element of refluxate. Investigation of molecular pathways involved in pepsin‐mediated damage may lead to identification of novel biomarkers and therapeutic targets for LPR. In this study, RNA sequencing was used to examine changes in human laryngeal epithelial cells following brief pepsin insult. Cells were immortalized to generate a model to aid future study of laryngeal injury and therapeutics.

[1]  J. Gould,et al.  Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma , 2019, The Laryngoscope.

[2]  R. Rosen,et al.  Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium , 2019, Scientific Reports.

[3]  Michael T. Zimmermann,et al.  RITAN: rapid integration of term annotation and network resources , 2019, PeerJ.

[4]  Jie Wang,et al.  Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma , 2019, Cancer Cell International.

[5]  B. Verdon,et al.  Establishment of an immortalized human subglottic epithelial cell line , 2019, The Laryngoscope.

[6]  J. Yun,et al.  Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro , 2018, PloS one.

[7]  P. Tassone,et al.  MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches , 2018, Journal of Hematology & Oncology.

[8]  C. Woods,et al.  Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls? , 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[9]  Charles A. Riley,et al.  Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients , 2017, JAMA otolaryngology-- head & neck surgery.

[10]  K. Huse,et al.  Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant , 2017, PloS one.

[11]  Qiang Hu,et al.  Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis , 2017, PloS one.

[12]  J. Tan,et al.  [The expression and significance of pepsin in laryngeal carcinoma]. , 2016, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[13]  Gwang Ha Kim,et al.  Clinical Manifestations of Laryngopharyngeal Reflux , 2016, Journal of neurogastroenterology and motility.

[14]  J. Viola,et al.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player , 2016, Cell Death and Disease.

[15]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[16]  C. Wahlestedt,et al.  Antisense RNA controls LRP1 Sense transcript expression through interaction with a chromatin-associated protein, HMGB2. , 2015, Cell Reports.

[17]  I. Hočevar-Boltežar,et al.  Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer , 2015, Radiology and oncology.

[18]  Sang-Hyuk Lee,et al.  Establishment of an immortalized laryngeal posterior commissure cell line as a tool for reflux research , 2015, The Laryngoscope.

[19]  Hui Chen,et al.  Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma , 2014, Medical Oncology.

[20]  L. Aaltonen,et al.  Identification of 33 candidate oncogenes by screening for base-specific mutations , 2014, British Journal of Cancer.

[21]  Su-Hyung Hong,et al.  LRP1-dependent pepsin clearance induced by 2'-hydroxycinnamaldehyde attenuates breast cancer cell invasion. , 2014, The international journal of biochemistry & cell biology.

[22]  P. Funch‐jensen,et al.  Proton pump inhibitor use may not prevent high‐grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients , 2014, Alimentary pharmacology & therapeutics.

[23]  E. A. Kelly,et al.  Chronic Pepsin Exposure Promotes Anchorage-Independent Growth and Migration of a Hypopharyngeal Squamous Cell Line , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  Yan-ning Gao,et al.  Identification of Human Tissue Kallikrein 6 as a Potential Marker of Laryngeal Cancer Based on the Relevant Secretory/Releasing Protein Database , 2014, Disease markers.

[25]  A. Campagnolo,et al.  Laryngopharyngeal Reflux: Diagnosis, Treatment, and Latest Research , 2013, International Archives of Otorhinolaryngology.

[26]  M. Vaezi,et al.  High Economic Burden of Caring for Patients With Suspected Extraesophageal Reflux , 2013, The American Journal of Gastroenterology.

[27]  G. Stoner,et al.  Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells , 2012, The Laryngoscope.

[28]  K. Bardhan,et al.  Reflux Revisited: Advancing the Role of Pepsin , 2011, International journal of otolaryngology.

[29]  D. Vynios,et al.  Head and neck: Laryngeal tumors: an overview , 2011 .

[30]  Seung Hwan Lee,et al.  The Role of Laryngopharyngeal Reflux as a Risk Factor in Laryngeal Cancer: A Preliminary Report , 2011, Clinical and experimental otorhinolaryngology.

[31]  A. Morice,et al.  Review article: reflux and its consequences – the laryngeal, pulmonary and oesophageal manifestations , 2011, Alimentary pharmacology & therapeutics.

[32]  D. Beer,et al.  Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome , 2011, Clinical Cancer Research.

[33]  J. Blumin,et al.  Rationale for Targeting Pepsin in the Treatment of Reflux Disease , 2010, The Annals of otology, rhinology, and laryngology.

[34]  Tina L Samuels,et al.  Pepsin as a Marker of Extraesophageal Reflux , 2010, The Annals of otology, rhinology, and laryngology.

[35]  Tina L Samuels,et al.  Pepsin as a causal agent of inflammation during nonacidic reflux , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[36]  J. Blumin,et al.  Pepsin in Nonacidic Refluxate Can Damage Hypopharyngeal Epithelial Cells , 2009, The Annals of otology, rhinology, and laryngology.

[37]  T. Shpitzer,et al.  T1 glottic carcinoma involving the posterior commissure , 2009, The Laryngoscope.

[38]  D. Castell,et al.  An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  E. Hill,et al.  Characteristics of Symptomatic Reflux Episodes on Acid Suppressive Therapy , 2008, The American Journal of Gastroenterology.

[40]  J. Koufman,et al.  Activity/Stability of Human Pepsin: Implications for Reflux Attributed Laryngeal Disease , 2007, The Laryngoscope.

[41]  R. Ramirez,et al.  Acid Has Antiproliferative Effects in Nonneoplastic Barrett's Epithelial Cells , 2007, The American Journal of Gastroenterology.

[42]  K. Takeuchi,et al.  Essential Role of Pepsin in Pathogenesis of Acid Reflux Esophagitis in Rats , 2006, Digestive Diseases and Sciences.

[43]  M. Birchall,et al.  The isolation and characterisation of primary human laryngeal epithelial cells. , 2005, Molecular immunology.

[44]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Lyttle,et al.  Changing Impact of Gastroesophageal Reflux in Medical and Otolaryngology Practice , 2005, The Laryngoscope.

[46]  J. Koufman,et al.  Patients with Isolated Laryngopharyngeal Reflux are not Obese , 2005, The Laryngoscope.

[47]  A. Gasbarrini,et al.  Association of Laryngeal Cancer With Previous Gastric Resection , 2004, Annals of surgery.

[48]  A. Franchi,et al.  Epidermal growth factor receptor and p53 expression in T1–T2 glottic cancer involving the anterior or posterior commissure , 2004, Acta oto-laryngologica.

[49]  R. Fisher,et al.  Comparison of a Salivary/Sputum Pepsin Assay with 24-Hour Esophageal pH Monitoring for Detection of Gastric Reflux into the Proximal Esophagus, Oropharynx, and Lung , 2003, Digestive Diseases and Sciences.

[50]  J. Koufman,et al.  Cell Biology of Laryngeal Epithelial Defenses in Health and Disease: Further Studies , 2003, The Annals of otology, rhinology, and laryngology.

[51]  Petr Beneš,et al.  C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer , 2003, Breast Cancer Research.

[52]  P. Romagnoli,et al.  Risk Factors and Prognosis of Anterior Commissure versus Posterior Commissure T1-T2 Glottic Cancer , 2003, The Annals of otology, rhinology, and laryngology.

[53]  A. Ikai,et al.  Inhibition of Human Pepsin and Gastricsin by α2-Macroglobulin , 2003 .

[54]  J. Koufman,et al.  Prevalence of Reflux in 113 Consecutive Patients with Laryngeal and Voice Disorders , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[55]  M. Wax,et al.  Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch. , 2000, Archives of otolaryngology--head & neck surgery.

[56]  J. Koufman.  The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury , 1991, The Laryngoscope.

[57]  D. Piper,et al.  pH stability and activity curves of pepsin with special reference to their clinical importance. , 1965, Gut.

[58]  M. Rezaei-Tavirani,et al.  Introducing Potential Key Proteins and Pathways in Human Laryngeal Cancer: A System Biology Approach , 2018, Iranian journal of pharmaceutical research : IJPR.

[59]  G. Ciprandi,et al.  Focus on gastroesophageal reflux (GER) and laryngopharyngeal reflux (LPR): new pragmatic insights in clinical practice. , 2018, Journal of biological regulators and homeostatic agents.

[60]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[61]  A. Ikai,et al.  Inhibition of human pepsin and gastricsin by alpha2-macroglobulin. , 2003, Journal of enzyme inhibition and medicinal chemistry.

[62]  J. Koufman,et al.  Symptoms and findings of laryngopharyngeal reflux. , 2002, Ear, nose, & throat journal.

[63]  D. Ruiter,et al.  Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords. , 1996, Acta oto-laryngologica.